Neuropharmacological Interventions in Neurodegenerative Disorders

This track is dedicated to exploring pharmacological strategies for treating neurodegenerative disorders such as Alzheimer’s, Parkinson’s, and Huntington’s disease. Researchers are encouraged to submit abstracts on novel drug candidates, mechanisms of action, and clinical trial results. The track will cover both symptomatic treatments and disease-modifying therapies, with a focus on advancing our understanding of neurodegenerative processes. Attendees will learn about the latest therapeutic approaches that aim to slow or halt the progression of these debilitating diseases.

    Related Conference of Neuropharmacological Interventions in Neurodegenerative Disorders

    April 27-28, 2026

    11th World Kidney Congress

    London, UK
    June 29-30, 2026

    18th World Nephrology Summit

    Aix-en-Provence, France
    August 27-28, 2026

    30th European Nephrology Conference

    Berlin, Germany
    November 10-11, 2026

    13th World Congress on Epidemiology & Public Health

    Amsterdam, Netherlands
    March 29-30, 2027

    23rd World Nephrology Conference

    Amsterdam, Netherlands

    Neuropharmacological Interventions in Neurodegenerative Disorders Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in